Zai Lab (ZLAB) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
0.9bn → 1.1bn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
+43.2% YoY in FY25 · 1.8% of revenue.
$0.9M returned vs $−158.9M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.
-38¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Over this window: gross 63.8% → 58.5%. Net margin -38.1% is below the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 441.7 | 460.2 | 399.0 | 266.7 | 215.0 | 144.3 | ▲15.3% | +33.6% |
Cost of revenue | 200.1 | 191.1 | 147.9 | 95.8 | 74.0 | 52.2 | ▲29.2% | +38.3% |
Gross profit | 241.6 | 269.1 | 251.1 | 170.9 | 141.0 | 92.1 | ▲7.1% | +30.7% |
Research & development | 238.8 | 220.9 | 234.5 | 265.9 | 286.4 | 573.3 | ▼5.8% | −21.2% |
Selling, general & admin | 281.1 | 277.6 | 298.7 | 281.6 | 259.0 | 218.8 | ▼7.1% | +6.1% |
Total operating expenses | 519.9 | 498.5 | 533.2 | 537.5 | 545.4 | 792.1 | ▼6.5% | −10.9% |
Operating incomefeeds ROC rank | −278.3 | −229.4 | −282.1 | −366.6 | −404.4 | −700.1 | ▲18.7% | — |
Other income, net | 75.5 | 51.0 | 25.0 | 32.0 | −38.7 | −3.4 | — | — |
Pretax income | −202.8 | −178.5 | −257.1 | −334.6 | −443.1 | −703.4 | ▲30.6% | — |
Income tax | −4.4 | −2.9 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −198.4 | −175.5 | −257.1 | −334.6 | −443.3 | −704.5 | ▲31.7% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.19 | −0.16 | −0.26 | −0.35 | −0.46 | −0.76 | ▲38.5% | — |
Diluted shares (bn) | 1.12 | 1.10 | 0.99 | 0.97 | 0.96 | 0.93 | ▲10.7% | +4.2% |
| Margins | ||||||||
Gross margin35th pct in Healthcare | 54.7% | 58.5% | 62.9% | 64.1% | 65.6% | 63.8% | ▼4.5pp | −5.3pp |
Operating margin | −63.0% | −49.9% | −70.7% | −137.4% | −188.0% | −485.1% | ▲20.8pp | +435.2pp |
Net margin15th pct in Healthcare | −44.9% | −38.1% | −64.4% | −125.5% | −206.1% | −488.2% | ▲26.3pp | +450.0pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Zai Lab's revenue last fiscal year?
Zai Lab reported revenue of $460.2M in fiscal 2025, up 15.3% from fiscal 2024.
What was Zai Lab's net income?
Zai Lab reported net income of −$175.5M in fiscal 2025, a net margin of −38.1%.

